Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma - Wikidata - awgldk - TriplyDB

Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma

Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma

http://www.wikidata.org/entity/Q24614307

about

Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.Stage-related alterations in renal cell carcinoma--comprehensive quantitative analysis by 2D-DIGE and protein network analysis.Global proteomics and metabolomics in cancer biomarker discovery.Discovery of mouse spleen signaling responses to anthrax using label-free quantitative phosphoproteomics via mass spectrometry.Towards the integration, annotation and association of historical microarray experiments with RNA-seq Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.Proteomic biomarker discovery: it's more than just mass spectrometry.Multi-biomarker pattern for tumor identification and prognosis.The proteomic landscape of renal tumors.Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery.Protocol for the Analysis of Laser Capture Microdissected Fresh-Frozen Tissue Homogenates by Silver-Stained 1D SDS-PAGE.Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers.The crucial role of multiomic approach in cancer research and clinically relevant outcomes.Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics.

P2860

Q28237085-AD53DAFE-2C01-4960-A05D-688505558126 Q28307595-5160F356-CC86-4F40-B9F7-CD49B6B526A4 Q28710385-9B58DC0F-7DAD-4633-88F4-413D28C92E0D Q30928926-432BB702-D8A4-4C67-BF1B-477270F60C05 Q33961565-F755CD9E-392A-4F9B-9933-FDC39DF82D3D Q34079038-F2663A5D-6676-42B1-BBD1-357DDD14867B Q34616750-59AEF1A4-013A-436A-92B1-DF3368BCBBBD Q35051525-B8A5673B-B9CD-487D-9D73-8B18407EEFB9 Q37686308-62D31384-7FDD-4EF9-AFD1-7678ADF39BCD Q37859348-4C1D95A3-2C71-444A-A048-C7984B682EDD Q37873877-EB2B0FC8-9159-4445-890F-DBA92EFA7745 Q37890322-07C23CB9-8CA2-4FA8-8F59-3CE6B77D46CD Q38803559-6635A031-78FC-43C9-B150-79B79AB816E6 Q47951557-3AB8D7CB-D755-406C-9802-C626944331F0 Q49979863-A524351B-8366-4558-9347-8F020E2FB4F9 Q52354794-AB35C833-18D3-40A0-99A7-EE1A5D4D76F9 Q52363678-C3C51537-2DB4-46F7-8B62-A562976EA503 Q55113686-6CB46C9A-8651-44CF-8C8F-47E9E7265409

P2860

Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma

http://www.wikidata.org/entity/Q24614307

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Combined blood/tissue analysis ...... cation to renal cell carcinoma

@ast

Combined blood/tissue analysis ...... cation to renal cell carcinoma

@en

Combined blood/tissue analysis ...... cation to renal cell carcinoma

@nl

type

label

Combined blood/tissue analysis ...... cation to renal cell carcinoma

@ast

Combined blood/tissue analysis ...... cation to renal cell carcinoma

@en

Combined blood/tissue analysis ...... cation to renal cell carcinoma

@nl

prefLabel

Combined blood/tissue analysis ...... cation to renal cell carcinoma

@ast

Combined blood/tissue analysis ...... cation to renal cell carcinoma

@en

Combined blood/tissue analysis ...... cation to renal cell carcinoma

@nl

P1433

Q24614307-6838E0A0-07F4-4A15-AD9A-68CE2F610F98

P1476

Q24614307-7FD7F96F-B795-4319-A960-EC22483C3473

P2093

Q24614307-160A95F5-A7B1-43FA-A453-D68C58C63CA6

Q24614307-287067CF-6EFF-4DCB-A164-04CDB06D428F

Q24614307-38F4807F-51AB-410D-851A-F32FFA0D5248

Q24614307-5E3BACEE-889B-4E20-87FC-AE18022AB2F7

Q24614307-6A0FB160-470C-4844-9511-7D0A14A33320

Q24614307-723846B3-4954-4037-8DEE-BC99D28C2A62

Q24614307-9CB417BC-2CA8-42B9-BA33-45AC03A859BF

Q24614307-9E55D725-3981-402E-8595-5D5BEEDEB473

Q24614307-AEF660BC-F2DE-40B0-BDBD-34F15AF39638

Q24614307-B8F5F3A2-ABA0-4576-8F3F-C121DA24E6A8

P2860

Q24614307-0031E2CE-E3FC-4613-95AC-4D1C84FB8CC8

Q24614307-0444DA90-86D5-43E4-B583-47EE56A984D3

Q24614307-11CE5873-E2AF-4E23-9B6F-05B31D0D29B6

Q24614307-179B89FE-E964-4129-9462-96463689DAE2

Q24614307-2A69542E-0F40-41B7-B7C1-3372642E4C59

Q24614307-3005C347-4EBD-4D35-9368-B30D077B791F

Q24614307-52B95339-5713-4801-AD20-62D188778D42

Q24614307-57D024FD-2D35-4356-80B2-1176CFCC81B6

Q24614307-5EC778F3-BDA5-4DCD-B033-716976C7051B

Q24614307-71B80FE5-230E-4267-A7C3-FC83C19F5826

P304

Q24614307-1268F664-C93E-4862-87DE-6AC3FC443A53

P31

Q24614307-BD7FE2A5-EDAF-4534-BD96-CA8AC07D8A02

P356

Q24614307-09D507DF-86D9-4210-985C-27DAF19118F1

P407

Q24614307-DA2C6EA3-2138-42DE-8EE5-845490D6489C

P433

Q24614307-121849FD-5319-4C50-B14A-CD50DF33E581

P478

Q24614307-8FBA91CB-96C3-4729-A203-6B6EF6FA87D0

P577

Q24614307-D5FED852-1963-4CBB-B37D-A6ADAAAECBE7

P5875

Q24614307-007323B4-402A-46EA-9040-5ABC026AE826

P698

Q24614307-EF9D7804-AAB8-4F7E-9392-D5D9A50D680C

P921

Q24614307-1E15CEFB-B20B-4BB5-922F-10C34D1485B1

P932

Q24614307-E8DB4BEC-09D9-417A-98B0-E855D98F1A15

P356

P1433

Analytical Chemistry

P1476

Combined blood/tissue analysis ...... cation to renal cell carcinoma

@en

P2093

Bih-Rong Wei

http://www.w3.org/2001/XMLSchema#string

DaRue A Prieto

http://www.w3.org/2001/XMLSchema#string

Donald J Johann

http://www.w3.org/2001/XMLSchema#string

Haleem J Issaq

http://www.w3.org/2001/XMLSchema#string

Josip Blonder

http://www.w3.org/2001/XMLSchema#string

King C Chan

http://www.w3.org/2001/XMLSchema#string

Paul A Rudnick

http://www.w3.org/2001/XMLSchema#string

R Mark Simpson

http://www.w3.org/2001/XMLSchema#string

Stephen E Stein

http://www.w3.org/2001/XMLSchema#string

Timothy D Veenstra

http://www.w3.org/2001/XMLSchema#string

P2860

Essential role of KIBRA in co-activator function of dynein light chain 1 in mammalian cells

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

Nuclear membrane proteins with potential disease links found by subtractive proteomics

The human Mi-2/NuRD complex and gene regulation

A model for random sampling and estimation of relative protein abundance in shotgun proteomics

The microenvironment of the tumour-host interface

Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry

Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI).

Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling.

Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.

P304

1584-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/AC902204K

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41396584

http://www.w3.org/2001/XMLSchema#string

P698

20121140

http://www.w3.org/2001/XMLSchema#string

P921

P932

3251958

http://www.w3.org/2001/XMLSchema#string